Approximately 980,000 tablets of a prescription medicine to treat high blood pressure have been ordered removed from pharmacy shelves, with a full recall to be completed by early August after being found to contain an insufficient amount of a key ingredient, the Food and Drug Administration (FDA) announced Wednesday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
-
Cross-Strait
MAC condemns retired officer's China trip, backs legal changes
04/26/2026 09:05 PM -
Society
Suspect ordered detained for attack on 3-year-old Filipino child
04/26/2026 06:47 PM -
Business
Taiwan drone exports top US$100 million in Q1: MOEA
04/26/2026 06:05 PM -
Politics
Lai thanks Eswatini in video address for its support of Taiwan
04/26/2026 04:48 PM -
Society
Rockslide damages Suhua Highway tunnel; traffic limited to one lane
04/26/2026 02:39 PM